Table 2 Demographic characteristics: ATP immunogenicity cohorts at Day 21 in both studies
Characteristic | Categories | Study in adults | Study in children | |||
|---|---|---|---|---|---|---|
Q-Pan | D-Pan | Q-Pan0.9 | D-Pan0.9 | Q-Pan1.9 | ||
N | 164 | 164 | 76 | 75 | 58 | |
Age (years) | Mean (SD) | 39.7 (11.98) | 40.1 (11.74) | 6.0 (2.03) | 6.0 (2.02) | 6.0 (2.00) |
Range | 18-60 | 19-60 | 3-9 | 3-9 | 3-9 | |
Gendern (%) | Female | 75 (45.7) | 86 (52.4) | 30 (39.5) | 38 (50.7) | 27 (46.6) |
Male | 89 (54.3) | 78 (47.6) | 46 (60.5) | 37 (49.3) | 31 (53.4) | |
Racen (%) | African/African American | 3 (1.8) | 2 (1.2) | 0 | 0 | 0 |
Central/South/East & Southeast Asian | 0 | 0 | 76 (100) | 75 (100) | 56 (100) | |
Arabic/North African | 3 (1.8) | 0 | 0 | 0 | 0 | |
Caucasian/European | 158 (96.3) | 162 (98.8) | 0 | 0 | 0 | |